I am grateful for the opportunity to open this debate on the report “Eliminating Hepatitis C in Scotland: A Call to Action”, and I put on record my thanks to all those who contributed to the report and to colleagues from across the chamber who signed my motion enabling this afternoon’s debate to take place.
The report was produced by the Hepatitis C Trust in collaboration with clinicians, support workers, representatives of the pharmaceutical industry and MSPs from each party that is represented in the Scottish Parliament. As such, the report reflects the views of a representative cross-section of those who are working to treat and to eliminate hepatitis C.
The objective of the inquiry, as described in the report, was
“to map progress toward the Scottish Government’s world-leading commitment to hepatitis C elimination, and develop recommendations to ensure elimination is achieved.”
In both of those areas, the report makes an important and considered contribution to our understanding of both where we currently stand and where we need to get to if elimination of hepatitis C is to be achieved. Before considering some of the specific recommendations that are made in the report, I will give an outline of what hepatitis C is, who it affects and why elimination is an important public health goal that warrants our attention and continued support.
Hepatitis C is a blood-borne virus that, if left untreated, can lead to degeneration of the liver and severe liver disease, potentially resulting in the need for a liver transplant. In Scotland and across the United Kingdom, the virus is predominately spread through the sharing of unsterilised equipment used to inject recreational drugs. Sharing needles for the injection of steroids also presents a risk of transmission, as would the use of unsterilised equipment for tattooing, acupuncture or body piercing. Other means of transmission are possible, such as unprotected sex, but they are less common. It is estimated that 35,000 people in Scotland carry the hepatitis C virus, of whom 15,000 are thought to be undiagnosed. We can compare that to the estimated 6,000 individuals in Scotland who are HIV positive, of whom 800 are believed to be unaware of their status.
In both testing and treatment, there have been significant advances in recent years. Dried blood-spot testing offers a simple and accurate way to determine one’s hepatitis C status. Treatment is now highly effective and safe and of a relatively short duration. However, that was not always the case. Prior to the introduction of all-oral direct-acting antiviral therapies, treating hepatitis C commonly required a long and demanding regime of interferon, which was often ineffective and could cause severe and debilitating side-effects. Therefore, it was not uncommon for people with hepatitis C to be unable to complete a treatment regime. Indeed, some chose actively not to seek treatment due to the potential for an adverse reaction. That is understandable, particularly given that many people with hepatitis C are initially asymptomatic.
Unfortunately, despite the availability of new treatments, many of the fears that dissuaded people from having a test or seeking treatment persist. It is, therefore, vital that we, as individual MSPs and as a Parliament, send a clear message: if you think you may have been exposed to hepatitis C at any time in your life or are concerned about your status, please reach out and seek support. That could mean reaching out to a general practitioner or other health professional or to one of the excellent support charities such as Hepatitis Scotland, the Hepatitis C Trust or Waverley Care. Whatever way people wish to engage and seek support in, the important thing for them to remember is that there is no need to worry in silence.
That last point speaks to the first area of focus in the report: the need to raise awareness. As I have indicated, it is estimated that over 40 per cent of those who are living with hepatitis C in Scotland do not know their status. Some may suspect, while others may have no indication at all. For those who are concerned that they may have been exposed to hepatitis C, one of the key barriers to testing is stigma. Although the report recognises that stigma has decreased in recent years, it states that stigma
“was reported as being still highly prevalent, and considered more significant among some groups than the stigma attached to HIV.”
It goes on to say:
“The effect of such stigma can be to prevent individuals from accessing testing for the virus, with some refusing to even consider the idea that they could be infected due to fear of being stigmatised if diagnosed.”
That stigma stems directly from the fact that hepatitis C predominately affects people who have previously injected, or who currently inject, drugs for recreational use. The report reinforces calls to recalibrate our thinking on substance misuse and understand it as a public health issue.
The report also highlights the need to raise awareness among lesser-known at-risk groups, such as users of image-enhancing and performance-enhancing drugs; men who have sex with men—a group in which awareness of hepatitis C is often lower than awareness of HIV; and the south Asian community, in which the prevalence of hep C is greater than in the wider population as a result of the widespread reuse of needles and razors in some south Asian countries.
The report makes a series of recommendations to address those challenges. First, it asks
“The Scottish Government to investigate the feasibility of a national awareness campaign.”
Secondly, it calls on
“High-profile public figures to use World Hepatitis Day”,
which takes place each year on July 28,
“as an opportunity to speak out, publicly highlighting risk factors, the importance of testing and ease of treatment.”
Thirdly, the report recommends that we target awareness-raising messages to lesser-known at-risk groups: in gyms, to users of image-enhancing and performance enhancing drugs; in sexual health services, to men who have sex with men; and in religious and community centres that are attended by members of the south Asian community. The report also recommends additional awareness training and support for GPs, particularly given that the symptoms that are associated with hepatitis C can be easily misdiagnosed.
All the recommendations that I have just outlined would have a positive impact in raising awareness and changing attitudes towards hepatitis C. In the context of broader public health challenges, it would be relatively straightforward to implement them.
In my remarks concerning the report, I have focused on the issue of awareness. However, the report presents evidence and recommendations on prevention, testing and diagnosis, linkage to care and access to treatment and funding. I look forward to hearing the thoughts of colleagues on all sides of the chamber on those aspects of the report, and I strongly encourage anyone who has not yet done so to read the report.
In concluding, I make clear my view, and the view of all those who were involved in producing the report, that Scotland has a truly great opportunity to continue to be world leading in the treatment of hepatitis C and to achieve elimination by 2030, or perhaps even sooner. We must not let the chance slip from our grasp. Let us redouble our efforts, make elimination a reality and consign hepatitis C to history.